Intravenous Methotrexate as Initial Treatment for Primary Central Nervous System Lymphoma: Response to Therapy and Quality of Life of Patients

[1]  B W Corn,et al.  Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? , 1997, Cancer.

[2]  F. Hochberg,et al.  Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD) , 1996, Journal of Neuro-Oncology.

[3]  G. Harsh,et al.  Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy , 1996, Neurology.

[4]  L. Deangelis,et al.  Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients , 1996, Neurology.

[5]  D. Cella,et al.  The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors , 1995, Cancer.

[6]  P. Burger,et al.  Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma , 1994, Neurology.

[7]  N. Harris,et al.  Pathology with clinical correlations of primary central nervous system non‐Hodgkin's lymphoma. The massachusetts general hospital experience 1958‐1989 , 1994, Cancer.

[8]  F. Hochberg,et al.  Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. , 1994, Journal of neurosurgery.

[9]  E. Neuwelt,et al.  Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Neuwelt,et al.  Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. , 1993, Neurosurgery.

[11]  N. Mackworth,et al.  Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores , 1992, Journal of Neuro-Oncology.

[12]  L. Deangelis,et al.  Combined modality therapy for primary CNS lymphoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Braziel,et al.  Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Tangalos,et al.  The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.

[15]  J. Lowe,et al.  Primary non-Hodgkin's lymphoma of the central nervous system: phase II study of chemotherapy (BVAM) prior to radiotherapy. , 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

[16]  M. Maltoni,et al.  Primary Lymphoma of the Central Nervous System , 1991, Tumori.

[17]  Y. Shibamoto,et al.  Improved survival rate in primary intracranial lymphoma treated by high‐dose radiation and systemic vincristine‐doxorubicin‐cyclophosphamide‐prednisolone chemotherapy , 1990, Cancer.

[18]  H. Bloom,et al.  Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. , 1990, International journal of radiation oncology, biology, physics.

[19]  J. Flickinger,et al.  Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma , 1989, Cancer.

[20]  F. Hochberg,et al.  High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases. , 1989, Journal of neurosurgery.

[21]  P. Burger,et al.  Increasing incidence of primary brain lymphoma in the US , 1988, Cancer.

[22]  R. Kellner.  A symptom questionnaire. , 1987, The Journal of clinical psychiatry.

[23]  R. Zimmerman,et al.  Magnetic resonance imaging in the evaluation of treatment‐related central nervous system damage , 1986, Cancer.

[24]  N. T. Pedersen,et al.  Primary malignant lymphoma of the central nervous system. , 1985, Surgical neurology.

[25]  R. Kellner,et al.  Hypochondriacal Beliefs and Attitudes in Family Practice and Psychiatric Patients , 1984, International journal of psychiatry in medicine.

[26]  V. Smith,et al.  Therapeutic irradiation and brain injury. , 1980, International journal of radiation oncology, biology, physics.

[27]  K. Skullerud,et al.  Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia , 1978, Cancer.

[28]  M. Weissman,et al.  SOCIAL ADJUSTMENT BY SELF‐REPORT IN A COMMUNITY SAMPLE AND IN PSYCHIATRIC OUTPATIENTS , 1978, The Journal of nervous and mental disease.

[29]  M. Weissman,et al.  Assessment of social adjustment by patient self-report. , 1976, Archives of general psychiatry.

[30]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[31]  R. Davis,et al.  Primary malignant lymphomas of the central nervous system , 1974, Cancer.

[32]  J. P. O'sullivan,et al.  Encephalopathy in Acute Leukaemia Associated with Methotrexate Therapy , 1972, Archives of disease in childhood.

[33]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[34]  P. P. Heppner,et al.  Applications of the Problem Solving Inventory , 1997 .

[35]  H. Hirschberg,et al.  Primary Malignant Lymphoma of the Brain: A report of 24 cases from the Norwegian Radium Hospital , 1992 .

[36]  D. Nelson,et al.  Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. , 1992, International journal of radiation oncology, biology, physics.

[37]  P. Paul Heppner,et al.  The Problem Solving Inventory , 1988 .

[38]  L. Eapen,et al.  Cyclophosphamide, Adriamycin, vincristine, and dexamethasone in the treatment of bulky central nervous system lymphoma , 1986 .

[39]  K. Peterson,et al.  Depression and anxiety in cancer patients: evidence for different causes. , 1985, Journal of psychosomatic research.

[40]  R. Britt,et al.  Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. , 1984, Journal of neurosurgery.

[41]  P. Paul Heppner,et al.  The development and implications of a personal problem-solving inventory , 1982 .

[42]  D. Kufe,et al.  Treatment of central nervous system tumors with methotrexate. , 1981, Cancer treatment reports.

[43]  G. Rosen,et al.  Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. , 1980, Cancer treatment reports.

[44]  K. Jellinger,et al.  Primary malignant lymphomas of the central nervous system in man. , 1975, Acta neuropathologica. Supplementum.

[45]  S. Kramer.  The hazards of therapeutic iradiation of the central nervous system. , 1968, Clinical neurosurgery.